• About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • Bria-IMT Cell Therapy
    • Personalized Off-The-Shelf Immunotherapy
    • What is BriaCell’s Cancer Therapy?
    • Patents
    • Clinical Studies of Cancer Treatment
    • Scientific Publications
  • Patients
    • What is BriaCell’s Cancer Therapy?
    • How can MBC patients get BriaCell cancer therapy?
    • Clinical Trial
    • Expanded Access
  • Recent Media
  • Investor Relations
    • Presentation & Fact Sheet
    • News & Events
    • Filings & Shareholder Info
    • Stock Info
    • Analyst Coverage
    • BriaPro
    • Email Alerts
    • Contact Us
  • HOME
  • Sign Up for Email Alert
  • Careers
A blue and orange logo for briacell on a white background
BriaCell Logo
  • About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • Bria-IMT Cell Therapy
    • Personalized Off-The-Shelf Immunotherapy
    • What is BriaCell’s Cancer Therapy?
    • Patents
    • Clinical Studies of Cancer Treatment
    • Scientific Publications
  • Patients
    • What is BriaCell’s Cancer Therapy?
    • How can MBC patients get BriaCell cancer therapy?
    • Clinical Trial
    • Expanded Access
  • Recent Media
  • Investor Relations
    • Presentation & Fact Sheet
    • News & Events
    • Filings & Shareholder Info
    • Stock Info
    • Analyst Coverage
    • BriaPro
    • Email Alerts
    • Contact Us

BriaPro

Investor Relations

  • Presentation & Fact Sheet
  • News & Events
  • Filings & Shareholder Info
  • Stock Info
  • Analyst Coverage
  • BriaPro
  • Email Alerts
  • Contact Us
☰   INVESTOR MENU
  • Presentation & Fact Sheet
  • News & Events
  • Filings & Shareholder Info
  • Stock Info
  • Analyst Coverage
  • BriaPro
  • Email Alerts
  • Contact Us

AGM 2025

Press Release: AGM Materials Availability & Voting

AGM Materials Availability & Voting

Management Information Circular

Management Information Circular

2023 Annual Financial Statements

2023 Annual Financial Statements

2023 Annual MD&A

2023 Annual MD&A

2024 Annual Financial Statements

2024 Annual Financial Statements

2024 Annual MD&A

2024 Annual MD&A

Voting Instruction Form (SEDAR version)

Voting Instruction Form (SEDAR version)

Form of Proxy (SEDAR version)

Form of Proxy (SEDAR version)

Code of Conduct

Code of Conduct

Financial Statement Request Form

Financial Statement Request Form

A blue and orange logo for briacell on a white background

Corporate Office - Canada

Suite 300 - Bellevue Centre, 235 -15th Street,
West Vancouver, BC V7T 2X1


Tel: 604-921-1810
Fax: 604-921-1898

Corporate Office - USA

2929 Arch Street, 3rd Floor
Philadelphia, PA 19104


Tel: 1-888-485-6340
Fax: 424-245-3719

  • About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • Bria-IMT Cell Therapy
    • Personalized Off-The-Shelf Immunotherapy
    • What is BriaCell’s Cancer Therapy?
    • Patents
    • Clinical Studies of Cancer Treatment
    • Scientific Publications
  • Patients
    • What is BriaCell’s Cancer Therapy?
    • How can MBC patients get BriaCell cancer therapy?
    • Clinical Trial
    • Expanded Access
  • Recent Media
  • Investor Relations
    • Presentation & Fact Sheet
    • News & Events
    • Filings & Shareholder Info
    • Stock Info
    • Analyst Coverage
    • BriaPro
    • Email Alerts
    • Contact Us

Copyright 2025 © BriaCell Therapeutics Corp. | All rights reserved | XML Sitemap | HTML Sitemap | Powered by ACCESS Newswire

Share by: